FindTrial
Sign In

Thulium laser vaporesection of the prostate versus standard transurethral resection of the prostate: used for transpulmonary thermodilution haemodynamic monitoring

Surgery for high-risk patients with benign prostatic hyperplasia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-12002006
Enrollment
Unknown
Registered
2012-03-14
Start date
2010-11-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

benign prostatic hyperplasia

Interventions

laser group:This group under tulium laser vaporesection of the prostate
TURP group:This group under traditional transurethral resection of the prostate (TURP)

Sponsors

Xuanwu Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
60 Years to 90 Years

Inclusion criteria

Inclusion criteria: The criteria for patient inclusion in this study were indications for the surgical treatment of BPH.

Exclusion criteria

Exclusion criteria: The exclusion criteria were patients with prostate cancer, bladder calculus, neurogenic bladder dysfunction, previous prostate surgery, urethral stricture or coagulopathy and any diseases that interfered with the PiCCOTM monitoring, such as severe heart or pulmonary diseases.

Design outcomes

Primary

MeasureTime frame
heart rate;central venous pressure;extravascular lung water index;intrathoracic blood volume index;mean arterial blood pressure;Stroke volume index;maximum urinary flow rate;International Prostate Symptom Score;Haemoglobin decrease;Serum sodium decrease;Operative duration;prostate-specific antigen;prostate-specific antigen;prostate volume;—

Countries

China

Contacts

Public ContactTong-wen Ou
outongwen@sohu.com+86 010 83198460

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026